Robert A. Hamm
Geen lopende functies
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Caroline Dorsa | F | 64 | 14 jaar | |
| Stephen Sherwin | M | 75 | 14 jaar | |
| Eric Rowinsky | M | 67 | 14 jaar | |
| Michael Dambach | M | 57 | 17 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Stelios Papadopoulos | M | 75 | 15 jaar | |
| William Rastetter | M | 75 | 19 jaar | |
| James Mullen | M | 65 | 21 jaar | |
| William Young | M | 79 | 11 jaar | |
| Craig Eric Schneier | M | 76 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 jaar |
| Christopher McGuigan | M | 65 |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 5 jaar |
| Hans-Peter Hasler | M | 68 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 8 jaar |
| Peter Kellogg | M | 67 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 7 jaar |
| Eric S. Hoffman | M | 54 | 5 jaar | |
| Alexander Denner | M | 54 | 14 jaar | |
| Brian Posner | M | 62 | 14 jaar | |
| Gabriele Cerrone | M | 52 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | 5 jaar |
| George Scangos | M | 76 | 7 jaar | |
| Samantha Truex | F | - | 8 jaar | |
| Phillip Sharp | M | 79 | 31 jaar | |
| Ken Bate | M | 73 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 jaar |
| Michael Astrue | M | 67 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 jaar |
| Richard Mulligan | M | 69 | 14 jaar | |
| Lawrence C. Best | M | 75 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
| Joseph Mara | M | 49 | - | |
| Lynne Sullivan | F | 58 | 10 jaar | |
| Gina Consylman | F | 52 | 3 jaar | |
| Nancy L. Leaming | F | 76 | 14 jaar | |
| A. Sanders | F | 60 | 6 jaar | |
| Ji Young Park | F | - | 4 jaar | |
| John Cox | M | 61 | 14 jaar | |
| Robert Gagnon | M | 49 | 7 jaar | |
| Eric W. Kimble | M | 58 | 5 jaar | |
| Cecilia Jones | F | 49 | - | |
| Christopher Watt | M | 59 | 11 jaar | |
| Mark Bodenrader | M | 51 | - | |
| Allen Kamer | M | 53 | 3 jaar | |
| John McCabe | M | 55 | 2 jaar | |
| Decebal Bora | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
| Michael LaBarre | M | 60 | 3 jaar | |
| Akshay Vaishnaw | M | 61 | 7 jaar | |
| Pratik Multani | M | 57 | 5 jaar | |
| Francesco Granata | M | 73 | 1 jaar | |
| Michael Panzara | M | 57 | 8 jaar | |
| Scott Anthony Climes | M | 59 | 2 jaar | |
| Dinah Sah | M | 63 | 6 jaar | |
| William Mccarthy | M | - | 1 jaar | |
| Andrea DiFabio | F | 55 | 11 jaar | |
| Diego Cadavid | M | 58 | 8 jaar | |
| Ben Harshbarger | M | 55 | 5 jaar | |
| Gisele Dion | F | 57 | 9 jaar | |
| Marc Schegerin | M | 48 | 4 jaar | |
| Mark Meltz | M | 50 | 5 jaar | |
| Steve Doares | M | - | 10 jaar | |
| Liisa I. Nogelo | F | 53 | 11 jaar | |
| Richard Francis | M | 55 | 8 jaar | |
| Dell Faulkingham | M | 51 | 9 jaar | |
| Bernard Ravina | M | 56 | 4 jaar | |
| Robin A. Walker | M | 55 | 8 jaar | |
| Jason Tardio | M | 47 | 9 jaar | |
| John Round | M | - | 3 jaar | |
| Daniel Char | M | 63 | 11 jaar | |
| Thomas F. Keller | M | 92 | - | |
| Torsten Rüdiger Goesch | M | 65 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 jaar |
| Arturo Molina | M | 65 | 4 jaar | |
| Alan Belzer | M | 91 | 10 jaar | |
| Bruce R. Ross | M | 83 | 13 jaar | |
| Alan B. Glassberg | M | 87 | 12 jaar | |
| Louis Sullivan | M | 90 |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | - |
| Raymond Pawlicki | M | 63 | 6 jaar | |
| Gregory Gorgas | M | 61 | 11 jaar | |
| Tony Kingsley | M | 60 | 6 jaar | |
| Burt Adelman | M | 71 | 16 jaar | |
| Stephen Tulipano | M | 65 | 8 jaar | |
| John F. Weidenbruch | M | 63 | 5 jaar | |
| Michael D. Kowolenko | M | 68 | - | |
| Carol Gallagher | M | 59 | 1 jaar | |
| Anne Cook | F | 62 | 13 jaar | |
| Michael Gilman | M | 69 | 6 jaar | |
| Connie Matsui | F | 70 | 18 jaar | |
| Mary L. Good | M | 93 | 10 jaar | |
| Frederick B. Oleson | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 jaar |
| Melissa Morandi | F | 59 | 2 jaar | |
| Curran Simpson | M | 62 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 jaar |
| Jane F. Amara | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 4 jaar |
| Elizabeth Woo | F | 57 | 12 jaar | |
| Bonne Adams | F | 47 | 2 jaar | |
| Darren Braccia | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 jaar |
| Katherine J. Turner | M | 70 | 4 jaar | |
| Jeff Krstich | M | 74 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 jaar |
| James Dentzer | M | 57 | 3 jaar | |
| David Hallal | M | 56 | 2 jaar | |
| John Dunn | M | 72 | 9 jaar | |
| Glenn F. Pierce | M | 68 | 5 jaar | |
| Michael R. Slater | M | 77 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 jaar |
| Morris Z. Rosenberg | M | 64 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 8 jaar |
| David D. Pendergast | M | 76 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 jaar |
| Sylvie Grégoire | M | 62 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 jaar |
| Michael Lytton | M | 67 | 2 jaar | |
| Marijn Dekkers | M | 65 | 2 jaar | |
| David W Miller | M | - | 7 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Robert A. Hamm
- Persoonlijk netwerk